Tag | Content |
---|
EnhancerAtlas ID | HS145-16967 |
Organism | Homo sapiens |
Tissue/cell | NHBE |
Coordinate | chr3:45682310-45683240 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
ESRRB | MA0141.3 | chr3:45682694-45682705 | TCAAGGTCAAA | + | 6.14 | Mecom | MA0029.1 | chr3:45682839-45682853 | CTTTATCTTATCTT | - | 6.79 | TFAP2C | MA0524.2 | chr3:45682358-45682370 | TGCCCTGGGGCT | - | 6.11 | ZIC3 | MA0697.1 | chr3:45682613-45682628 | GCACAGCTGGGGGTC | - | 6.17 |
|
| Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
SE_13455 | chr3:45683058-45683733 | CD34_Primary_RO01536 | SE_38488 | chr3:45681288-45682500 | HUVEC | SE_42193 | chr3:45681921-45682887 | Lung | SE_42193 | chr3:45683063-45683726 | Lung | SE_45828 | chr3:45682188-45690162 | Osteoblasts | SE_56181 | chr3:45682124-45683405 | u87 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH03I045638 | chr3 | 45680304 | 45689900 |
|
Enhancer Sequence | ATGAGGATTC GGATTTTGTC AAAAAGTGAG TGCAGGGGCA TTGCTGTTTG CCCTGGGGCT 60 GCACACCCTC CTGCTCTGTG AATGTCCCAC TTCCTGTCCA GTTCCAAAGA GCAGTTGGAA 120 TGTTGGAGAC TGGGCTTGTG TCTCAGCGGC TTCTCTTAGA CACTGGAGGT GACTTGTCTT 180 TTTTCAGTTA CCAGATTGCT GCCCTTTACC TCAGTTTTCA GCAGAAGGAG GCACCCGGGA 240 GCTCTGTGTC TCAGCTCTGC AGGTCCTGAG TGTGTCTCTG TGAGCCTCAA CACCATGGAG 300 ACGGCACAGC TGGGGGTCTG GGTGCATCTA GGGCATCCCC TCCTTCTTAG AAGAGAAAAT 360 GGGGGCAGAC AGGGGAAGAA TTTCTCAAGG TCAAAAACCT GGCTATGGAG CTGGCATGGA 420 ATCCAGACCT CTTGAATCTA TGCTCACCTG TACTTCCTTG TTTTTCTGGT TCTCCCTCCT 480 CTGATTTATT TCCACCTAGT CAAGCAAAAA TAAGTGTGTT TTCTCTGTTC TTTATCTTAT 540 CTTGGTTATT GATAGAGTCT GGTGAGTGTG TGTATTTCTG AACATACTTG TATATGTATC 600 TTTTCTATTT TCCCATTTCA ATTATGAAAA TCTAGTTTAA AACACTATAT ATAGTATGTA 660 AAGCCAGATT TTATATATAA TTATATATAT TTTATTTTAT TTATATTTTT TATATATATA 720 TAGCATATGG CATATGGAGG TATCTGTTGG TATATACACA TACTTCCTGA GGTCCATTGA 780 TACTGCATTA AACCATGGTA TTTGGATACT GTTAAGCTCA CACACATTTA CAGGGCAAGT 840 CCAGGGCCTG ACTAGTTTGG TAAAGATACA ACAAGCCACT GTTACTTTAG GCAGTTTATT 900 ACTTACATAG GCAGGCAACA CAAAGAATGT 930
|